DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 51 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $22,201,000 | -55.5% | 1,101,275 | -17.6% | 0.01% | -56.2% |
| Q2 2021 | $49,852,000 | +41.4% | 1,335,820 | -3.1% | 0.02% | +33.3% |
| Q1 2021 | $35,251,000 | -27.3% | 1,378,623 | -37.3% | 0.01% | -25.0% |
| Q4 2020 | $48,477,000 | +147.6% | 2,200,487 | +102.2% | 0.02% | +128.6% |
| Q3 2020 | $19,577,000 | -42.9% | 1,088,209 | -19.4% | 0.01% | -50.0% |
| Q2 2020 | $34,297,000 | -13.5% | 1,350,277 | -37.4% | 0.01% | -26.3% |
| Q1 2020 | $39,627,000 | -17.9% | 2,157,189 | -1.5% | 0.02% | +11.8% |
| Q4 2019 | $48,252,000 | +38.0% | 2,190,266 | -10.0% | 0.02% | +30.8% |
| Q3 2019 | $34,960,000 | -10.1% | 2,434,539 | -1.3% | 0.01% | -13.3% |
| Q2 2019 | $38,868,000 | +9.7% | 2,467,799 | +2.0% | 0.02% | 0.0% |
| Q1 2019 | $35,440,000 | +347.9% | 2,419,121 | +226.9% | 0.02% | +275.0% |
| Q4 2018 | $7,912,000 | +2.6% | 740,088 | +46.4% | 0.00% | +33.3% |
| Q3 2018 | $7,715,000 | +3.8% | 505,591 | -16.7% | 0.00% | 0.0% |
| Q2 2018 | $7,436,000 | +29.3% | 606,999 | +0.9% | 0.00% | +50.0% |
| Q1 2018 | $5,753,000 | +4.1% | 601,822 | -1.7% | 0.00% | 0.0% |
| Q4 2017 | $5,527,000 | +56.3% | 612,127 | -0.5% | 0.00% | 0.0% |
| Q3 2017 | $3,537,000 | +293.0% | 615,017 | +116.6% | 0.00% | – |
| Q2 2017 | $900,000 | -7.0% | 283,933 | -0.3% | 0.00% | -100.0% |
| Q1 2017 | $968,000 | +18.8% | 284,645 | +0.6% | 0.00% | – |
| Q4 2016 | $815,000 | -47.9% | 283,046 | +6.5% | 0.00% | -100.0% |
| Q3 2016 | $1,563,000 | +8126.3% | 265,775 | +4069.0% | 0.00% | – |
| Q2 2016 | $19,000 | +533.3% | 6,375 | +2534.3% | 0.00% | – |
| Q4 2015 | $3,000 | -72.7% | 242 | -81.2% | 0.00% | – |
| Q3 2015 | $11,000 | -21.4% | 1,289 | +28.9% | 0.00% | – |
| Q2 2015 | $14,000 | -78.5% | 1,000 | -63.2% | 0.00% | – |
| Q1 2015 | $65,000 | – | 2,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |